Background-Aortopulmonary collaterals (APCs) have been associated with increased morbidity after the Fontan operation. We aimed to quantify APC flow after bidirectional cavopulmonary connections and Fontan completions, using phase-contrast MRI, and to identify risk factors for the development of APCs. Methods and Results-APC blood flow was quantifiable in 24 of 36 retrospectively analyzed MRI studies. Sixteen studies were performed after the bidirectional cavopulmonary connections (group A) and 8 after the Fontan operation (group B). APC blood flow was calculated by subtracting the blood flow volume through the pulmonary arteries from that through the pulmonary veins. The ratio of pulmonary to systemic blood flow (Qp/Qs) was 0. 
W
hereas there is general agreement that aortopulmonary collaterals (APCs; Figure 1 ) develop frequently with a bidirectional cavopulmonary connections (BCPC) or Fontan circulation, controversy persists regarding their hemodynamic and clinical consequences. [1] [2] [3] [4] [5] Some investigators have found them to be associated with prolonged pleural effusions and even an increased mortality rate after the Fontan operation, whereas others could not confirm a deleterious effect. 2, 4 
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The contradicting nature of these reports may be related to the difficulty in assessing the magnitude of blood flow through collaterals angiographically. 1 Conventional angiographic grading of APCs is neither objective nor quantitative as the extent of visualization of the APCs varies widely according to where, how fast, and how much contrast medium is injected. 1, 6 Ichikawa et al 3 and Bradley et al 6 quantified the blood flow through APCs during cardiopulmonary bypass at the time of the Fontan operation by measuring the amount of blood returning to the left atrium and relating it to the pump flow delivered via the aortic cannula. This approach, although of academic value in elucidating the magnitude and risk factors for APCs, is not helpful in the patients' clinical management before the Fontan operation and does not allow for follow-up after the operation. Furthermore, it requires intracardiac access, which is not otherwise necessary when extracardiac modifications or catheter laboratory completions of the Fontan procedure are performed. Inuzuka et al 7 recently used nuclear imaging in combination with catheterization to quantify APC flow in BCPC patients. To date, no noninvasive and readily applicable method has been proposed to quantify APC blood flow in patients with functionally single ventricles, except for in a case report, using MRI. 8 ( Figure 1 ) It is conceptually possible to quantify APC blood flow by subtracting the pulmonary arterial from the pulmonary venous blood flow volume. 8 -10 MRI is the gold standard for the quantification of arterial flow volumes, 10, 11 and it has recently been shown that pulmonary venous flow volumes can be measured accurately using phase-contrast MRI. 12 We report the systematic use of MRI in the quantification of APC blood flow in patients after BCPC or modified Fontan procedure. We sought to investigate the risk factors for and hemodynamic consequences of these APCs.
Methods
We reviewed the MRI data of patients after BCPC as well as after a modified Fontan operation or completion of the Fontan circuit in the catheterization laboratory. We identified 36 studies between May 2003 and October 2007. Among these, APC flow was quantifiable in 24 studies performed in 19 patients. In the remaining 12 studies, APC quantification was not possible. It was precluded by susceptibility artifacts caused by pulmonary artery (PA) stents, vascular coils and clips, and septal occluder devices in the Fontan fenestration in 5 studies. In 7 studies, complex pulmonary venous anatomy prevented adequate flow measurements and hence APC quantification.
Four patients had more than 1 MRI examination. Eight patients had a Fontan-type circulation with an even distribution of male and female patients in this group. Twelve patients, 9 of them male, had undergone a BCPC but not a Fontan operation at the time of the MRI. One patient was in both groups because she underwent an MRI both before and after the Fontan procedure. The other patients had no comparative studies before and after the Fontan completion. Six of the 19 patients had had no surgically created systemic blood supply to the lungs, 1 had had a Sano shunt, and the remainder had had either a right-sided (nϭ10), left-sided (nϭ1), or bilateral (nϭ1) modified Blalock-Taussig shunt(s). One patient had a fenestrated extracardiac tunnel. Indications for the MRI were to assess patency of the Fontan circuit and PA anatomy, to look for pulmonary venous obstruction, and to quantify the degree of collateral blood flow from the systemic to the pulmonary circulation. The demographic patient data and primary cardiac diagnoses are summarized in Table 1 .
Most MRI studies were performed on a GE signa CV/I 1.5-T MRI scanner (General Electric Medical Systems, Milwaukee, Wis). After July 2007, 2 studies were carried out on a 1.5-T Avanto magnet (Siemens Medical Solutions, Erlangen, Germany). The phasecontrast MRI data were obtained using the following imaging parameters: minimum echo and repetition times, flip angle 20°; bandwidth, 31.25 kHz; 1 to 2 k-space lines per segment; number of excitations, 1 to 2; slice thickness, 4 to 5 mm; minimum field of view; matrix 256ϫ128 to 256; upper velocity limit, 150 cm/s; 20 or more reconstructed phases per cardiac cycle. Measurements were made across the ascending aorta at the level of the right PA, the descending aorta at the level of the diaphragm, the superior vena cava, branch Pas, and the individual pulmonary veins. The imaging plane for each vessel, including the pulmonary veins, was based on 2 localizer images that were parallel to the vessel long axis and orthogonal to each other. Patients younger than 6 years of age were examined under general anesthesia.
A commercially available work station (CV Flow, Medical Imaging Systems, Leiden, The Netherlands) was used for quantification of the flow volumes through the ascending aorta (Q AA ), the descending aorta at the diaphragm (Q DA ), the right and left PAs (Q RPA and Q LPA ), the individual pulmonary veins (Q PV ), and the superior vena cava (Q SVC ). In 3 studies showing sizable systemic venous collaterals between the superior and inferior vena caval systems, the volume of the systemic venous collateral runoff (Q runoff ) was also measured. All flow volumes were indexed to the body surface area of the patient. The following parameters were calculated from the measured flow volumes: 
Statistical Analysis
Continuous variables that follow a Gaussian distribution are presented as meanϮSD. Nonnormally distributed variables are given as medians and ranges. Proportions are presented as a frequency (%). Paired t tests were performed to compare demographic data and the results of the flow measurements between the 2 patient groups. The intraclass correlation coefficient was used to compare the 2 methods of calculating APC blood flow. Parametric (Pearson correlation analysis) and nonparametric (Mann-Whitney U test) correlation analysis were performed as appropriate.
Results
The results of the measurements are summarized in Table 2 . There was a good intraclass correlation between the APC Patients with a previous right-sided modified BlalockTaussig shunt had more APC flow to the right lung than those without a previous shunt on the right side (Table 3 , patients with pulmonary venous obstruction were excluded from this part of analysis). Only 2 patients had a history of left-sided shunts, so this could not be assessed as a risk factor for APCs. There was no difference in the magnitude of Qp/Qs or the degree of collateral formation in male versus female patients, right versus left aortic arch, and unilateral versus bilateral BCPC.
We previously reported the case of 1 patient, included in this analysis, who underwent 3 studies and developed massive APCs on the side of progressive and finally total occlusion of the left pulmonary veins. 8 One patient underwent an MRI before and after her Fontan completion: After the operation, the APC flow volume index decreased from 1.38 to 0.50 L/min/m 2 . The APC flow volume fraction decreased from 61.9% to 20.0%. After the Fontan operation, the oxygen saturation increased from 73% to 98%.
To assess the accuracy of our flow measurements, we compared the flow volume in the ascending aorta with the total venous return to the heart, that is, with the sum of pulmonary and systemic venous flows in patients with a BCPC situation and to the total pulmonary venous flow volume in patients with a Fontan circulation. If all the flow measurements were perfectly accurate, then the discrepancy between the total venous return to the heart and the ascending aortic flow would be zero. The discrepancy was 0.26Ϯ0.48 L/min/m 2 or 7.9Ϯ14.5% (0 to 44.0%) of flow through the ascending aorta (Q AA ) in the BCPC and 0.19Ϯ38 L/min/m 2 , corresponding to 7.1Ϯ11.3% (0 to 25.1%) of Q AA in the Fontan group (excluding the patient with the fenestrated Fontan conduit).
Discussion
The current study is the first to report the systematic use of cardiac MRI in the quantification of APC flow. This was successful in most patients. In almost one fourth, however, a complex venous anatomy, consisting of early branching and/or a tortuous course, flow measurement in at least 1 pulmonary vein was not possible. The internal validation of flows in this cohort confirms that the measurements of APC flow are accurate with an acceptable margin of error in the majority of patients. Sources of inaccuracy include the fact that several flow measurements were combined in the calculation of APC flows, each of which introducing a slight inaccuracy, but also, once again, by complex pulmonary vein anatomy. The 2 proposed methods of APC flow volume calculation (Q P minus Q PA versus Q AA minus Q S ) showed good agreement. Figure 2B shows that the 3 patients with the greatest differences in the APC flow volumes calculated by methods A and B all had lower flow volumes from method B than from method A, and all 3 had undergone a Norwood operation. Method B uses Q AA , Q SVC , and Q DA . We have recently demonstrated the accuracy of phase-contrast MRI measurements of these flows. This, however, may not be the case for Q AA after the Norwood procedure. In fact, the discrepancy of venous return to the heart and cardiac output in these outliers was much greater (up to 44.0% of Q AA ) than the overall mean in this cohort. A plausible explanation for the underestimation of APC flow by method B in these 3 patients is the inaccuracy of flow measurements in the reconstructed ascending aorta. Turbulence from competing flows at the aortopulmonary anastomosis and swirling flow in the large reconstructed aortic arch undermine the physical prerequisites for accurate phase-contrast flow velocity measurements. We postulate that method A (Q p minus Q PA ) should be the preferred method for APC flow volume calculation, especially in the presence of a previous Norwood or Damus-Kaye-Stansel procedure.
Four-dimensional phase-contrast imaging, 13,14 the acquisition of flow information in all directions within an imaging volume containing the heart and great vessels, was not available when the data that were used in this retrospective analysis was taken. This method holds promise particularly when flow at many different locations is to be measured as well as when the target is difficult since the optimal cut can be sought offline. The value of this approach has yet to be proven for small vessels: If the in-plane resolution in the resulting measurement plane is to be sufficient for pulmonary veins in young children, the scan time becomes quite long and quickly exceeds 15 minutes during which the patient must not move. Owing to extensive data processing, the results cannot be viewed until after the examination. The calculated APC flow in our BCPC cohort (1.42, 0.58 to 3.83 L/min/m 2 ) was comparable to that by Inuzuka et al, 7 who used a combined approach with nuclear imaging and catheterization (1.75Ϯ0.43 L/min/m 2 ). 7 Their method, however, relies on a number of assumptions, is invasive, requires ionizing radiation, and cannot be used in Fontan patients.
Our analysis revealed a surprisingly high degree of APC blood flow, leading to important left-to-right shunts, in some cases within only a few months of the BCPC operation. On average, the Qp/Qs in our BCPC cohort was much greater than that reported by Salim et al 15 (0.93Ϯ0.26 versus 0.61Ϯ0.07). This difference in the degree of left-to-right shunting between their study and ours may be partly related to a patient referral bias as, particularly in the earlier studies in our cohort, MRI tended to have been requested because of PA or pulmonary venous obstruction, which probably promotes APC development.
Using the formula (Q P -Q PA ) in normal volunteers, MRI showed that approximately 6.6% of the estimated cardiac output reaches the lungs via systemic arteries. 12 In contrast, all patients in the current study showed a substantial amount of APC flow, with the minimum APC flow constituting 15.3% and 17.3% of the ascending aortic flow in BCPC and Fontan patients, respectively ( Table 2 ).
The causes, risk factors, and the pathophysiology of the development of such collateral arteries in patients with single-ventricle physiology are not entirely clear. APC flow volumes, normalized to the patient's body surface area, were significantly smaller in patients with a Fontan circuit than in those with a BCPC (0.82 L/min/m 2 versus 1.42 L/min/m 2 , Pϭ0.05). These data suggest that APCs regress spontaneously after the Fontan operation as was the case in the patient who was investigated both before and after the Fontan operation. APCs have been reported to occur more commonly after a longer interval between the BCPC and Fontan operation. 3, 4 Likewise, in our study, patients who proceeded to BCPC at a younger age were more likely to develop APCs, and patients who were older at the time of the Fontan completion had a greater degree of left-to-right shunting. It is, therefore, tempting to speculate that a factor unique to the BCPC circulation promotes the formation of APCs. What exactly mediates the development of APCs is uncertain. They may be an adaptive mechanism during prolonged periods of cyanosis, decreased volume and velocity of flow, or promoted by absent pulsatility, a high transpulmonary gradient, low flow of blood to the lungs, or lack of hepatic venous effluent. 3, 4 Experimental studies showed that reduced blood flow to only 1 region of the lung results in localized collateralization limited to the hypoperfused area. 16 Similarly, in our study, a distribution of APCs that is limited to the obstructed lung could be seen in 2 patients with pulmonary vein obstruction (Figure 2) . Therefore, systemic undersaturation or humoral factors 17, 18 alone cannot serve to explain the pathophysiology of APC development because they would affect both lungs. Furthermore, if hypoxemia was the principal stimulus, an association of APC flow with lower oxygen saturations would be expected. The opposite was true in our study, as well as in that by Triedman et al. 1 We speculate that the velocity, pulsatility, and volume of flow are more important determinants of the development of APCs than oxygen saturation.
McElhinney et al 1 and Triedman et al 4 found an association between APCs and a previous Blalock-Taussig shunt. 1, 4 In agreement with these reports, patients in this cohort with a previous right-sided shunt had significantly less PA and more APC flow to that lung than those without a shunt. The mechanism by which Blalock-Taussig shunts promote the development of APCs is unclear but may be related to distortion of PA geometry. Pleural scarring and adhesions to the chest wall after placement of a Blalock-Taussig shunt may facilitate the recruitment of chest wall vessels into the network of APCs into the lung on that side.
The natural history of APCs and their effect on the long-term outcome of single-ventricle patients has yet to be properly investigated. 2, 3, 19 Whereas Ichikawa et al 3 reported APC flow rates of more than one third of total cardiopulmonary bypass flow to be predictors of early postoperative failure, patients within our cohort with as much as 52.4% of collateral flow went on to do well after the Fontan procedure. In a prospective, randomized study, Brown et al 5 did not find a different outcome within 3 months after the Fontan operation between patients who underwent coil occlusion of collaterals and those who did not. Nevertheless, other inves-tigators have shown that APCs predispose the patient to postoperative complications after the Fontan completion, including prolonged pleural effusions, death, or the need for early "take-down" of the Fontan pathway. 2, 3, 20, 21 A number of potential pathophysiological pathways for this have been conjectured, including increased ventricular preload as a result of the left-to-right shunt. 21 Although previous reports have found patients with APCs to have a higher Qp/Qs, this study is the first to unequivocally establish APCs as the origin of this left-to-right shunt. The recirculating blood through the collaterals imposes a volume load on the systemic ventricle, thereby counteracting one of the major goals of the BCPC, which is to volume-unload the ventricle. 4, 6, 8 Another potentially unfavorable consequence of APCs in BCPC and Fontan patients is the increase of PA and systemic venous pressures that must be low for a functioning single ventricle physiology. It has been shown that additional pulmonary blood flow through a surgically created systemicto-PA shunt raises upper central venous pressure in BCPC patients. 22 We were able to show that the APC blood flow competes with PA flow, likely via a rise in mean PA pressures. PVR, which was calculated taking into account the added pulmonary blood flow via APCs, correlated with the degree of left-to-right shunting. Our data indicate that PVR is elevated, at least partly, as a result of the chronic left-to-right shunt. Turbulent inflow through APCs competes with the passive laminar flow and results in energy loss within the Fontan pathway, which can be deleterious in a circulation that is powered by only 1 ventricle. 23 
Limitations
Given the small number of patients in each group, the fact that correlation analyses produced statistically significant results is remarkable. Further associations, however, were potentially obscured by the small sample size, particularly in the Fontan group, with only 8 studies. A multivariate analysis for risk factors for APCs was not possible. Intraindividual longitudinal data collection from serial MRI examinations would be valuable in determining the time course of collateral formation and their natural history in patients throughout their career within the Fontan palliation.
Left-to-right shunts via APCs occur in most if not all patients with single ventricles both before and after the Fontan operation. The volume-unloading effect of BCPC disappears with development of APCs in a significant number of cases. The magnitude and hemodynamic consequences of these shunts can be reliably assessed with MRI and are greater than thus far presumed; they interfere with the BCPC and Fontan physiology. Proceeding to the BCPC at a younger age and to the Fontan completion at an older age is associated with a greater left-to-right shunt through APCs.
Sources of Funding
Lars Grosse-Wortmann was supported by the "Rotationsprogramm," University of Aachen, Germany.
